Ototoxicity
Showing 1 - 25 of 163
Cancer, Ototoxicity, Drug-Induced, Quality of Life Trial (Patients suffering from chemo-induced ototoxicity)
Not yet recruiting
- Cancer
- +3 more
- Patients suffering from chemotherapy-induced ototoxicity
- (no location specified)
Jun 29, 2023
Head Neck Cancer Survivors, Head Neck Cancer Surviors Trial in Saint Louis (Ototoxicity Screening Protocol)
Not yet recruiting
- Head and Neck Cancer Survivors
- Cancer of the Head and Neck Surviors
- Ototoxicity Screening Protocol
-
Saint Louis, MissouriWashington University School of Medicine
Mar 16, 2023
Radiosurgery Induced Ototoxicity in Patients Treated
Recruiting
- Vestibular Schwannoma
- Ototoxicity
- Stereotactic radiosurgery
-
Geneva, SwitzerlandService d'ORL et Chirurge cervico-faciale, Hopitaux Universitair
Nov 30, 2022
Hearing Loss Ototoxic Trial (SENS-401 (R-Azasetron Besylate))
Not yet recruiting
- Hearing Loss Ototoxic
- SENS-401 (R-Azasetron Besylate)
- (no location specified)
Nov 16, 2022
Aminoglycoside Toxicity, Aminoglycoside-Induced Hearing Loss, Hearing Loss Trial in London, Poole (video game hearing tests,
Recruiting
- Aminoglycoside Toxicity
- +3 more
- video game hearing tests
- Audio-training
-
London, United Kingdom
- +1 more
May 11, 2023
Ototoxicity Trial in Charleston (Placebo, SPI-1005 Ebselen 200mg Capsule x1, SPI-1005 Ebselen 200mg Capsule x2)
Enrolling by invitation
- Ototoxicity
- Placebo
- +3 more
-
Charleston, South CarolinaMedical University of South Carolina
Dec 7, 2022
Ototoxic Hearing Loss Trial in Toronto (N-Acetyl Cysteine)
Recruiting
- Ototoxic Hearing Loss
- N-Acetyl Cysteine
-
Toronto, Ontario, CanadaOdette Cancer Centre, Sunnybrook Health Sciences Centre
Oct 24, 2022
Ototoxicity, Drug-Induced Trial in Cincinnati (Sodium Thiosulfate)
Recruiting
- Ototoxicity, Drug-Induced
- Sodium Thiosulfate
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Mar 6, 2023
Other Disorders of Vestibular Function, Bilateral, Bilateral Vestibular Deficiency (BVD), Gentamicin Ototoxicity Trial in
Not yet recruiting
- Other Disorders of Vestibular Function, Bilateral
- +9 more
- Labyrinth Devices MVI™ Multichannel Vestibular Implant System
-
Baltimore, MarylandJohns Hopkins School of Medicine
Jan 5, 2023
Other Disorders of Vestibular Function, Bilateral, Bilateral Vestibular Deficiency (BVD), Gentamicin Ototoxicity Trial in
Not yet recruiting
- Other Disorders of Vestibular Function, Bilateral
- +8 more
- Labyrinth Devices MVI™ Multichannel Vestibular Implant System
-
Baltimore, MarylandJohns Hopkins School of Medicine
Jan 5, 2023
Cisplatin Adverse Reaction Trial in Cairo (Rosuvastatin 10mg)
Recruiting
- Cisplatin Adverse Reaction
- Rosuvastatin 10mg
-
Cairo, EgyptKasr El-Aini Center of Radiation Oncology and Nuclear Medicine
Jul 26, 2021
Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV
Recruiting
- Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +28 more
- Cisplatin
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 16, 2022
Other Disorders of Vestibular Function, Bilateral, Bilateral Vestibular Deficiency (BVD), Gentamicin Ototoxicity Trial in
Recruiting
- Other Disorders of Vestibular Function, Bilateral
- +5 more
- Labyrinth Devices MVI™ Multichannel Vestibular Implant
-
Baltimore, MarylandJohns Hopkins School of Medicine
Aug 31, 2021
Brain Tumor, Medulloblastoma, Pineoblastoma Trial in Boston, Houston (proton beam radiation)
Active, not recruiting
- Brain Tumor
- +2 more
- proton beam radiation
-
Boston, Massachusetts
- +1 more
Sep 30, 2021
Brain Tumor, Low Grade Glioma, Astrocytoma Trial in Boston (Proton radiotherapy)
Active, not recruiting
- Brain Tumor
- +4 more
- Proton radiotherapy
-
Boston, Massachusetts
- +1 more
Sep 30, 2021
Osteosarcoma, Nephrotoxicity, Ototoxicity Trial in Philadelphia (Pantoprazole, High-dose methotrexate infusion duration)
Completed
- Osteosarcoma
- +2 more
- Pantoprazole
- High-dose methotrexate infusion duration
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Mar 2, 2020
QoL From Ototoxicity in Cancer Survivors
Suspended
- Hearing Loss, Sensorineural
- +3 more
- High frequency pure tone audiometry
-
Nottingham, Nottinghamshire, United KingdomNottingham University Hospitals NHS trust
Mar 24, 2020
Quality of Life of Long-term Ototoxicity in Cancer Survivors
Completed
- Quality of Life
- +4 more
- High frequency audiometry
- +3 more
-
Nottingham, Nottinghamshire, United KingdomUniversity of Nottingham
Mar 24, 2020
Cisplatin Induced Hearing Loss Trial in San Diego (OTO-104)
Terminated
- Cisplatin Induced Hearing Loss
-
San Diego, CaliforniaContact Otonomy call center for trial locations
Sep 14, 2020
Cisplatin Ototoxicity, Hearing Loss Trial in Portland (COMP-VA, Standard of care)
Completed
- Cisplatin Ototoxicity
- Hearing Loss
- COMP-VA
- Standard of care
-
Portland, OregonVA Portland Health Care System, Portland, OR
Sep 17, 2019
Web and Tablet-based Interactive Audiometry in Adults With CF
Completed
- Hearing Loss, Sensorineural
- Cystic Fibrosis
- Audiometry tablet diagnostic tool and web-based test
-
London, United KingdomDr Anand Shah
May 22, 2020
Cancer and Hearing Loss Related in Children
Completed
- Cancer in Children
- Hearing Loss
- Genetic study
- Genetic study MT-RN1
-
Paris, FranceInstitut Curie
Apr 30, 2021